CIENCIASMEDICASNEWS: Newly identified gene biomarker can distinguish atopic dermatitis and psoriasis with excellent accuracy

jueves, 13 de agosto de 2020

Newly identified gene biomarker can distinguish atopic dermatitis and psoriasis with excellent accuracy

	Dermatology
	The latest dermatology news from News Medical

Newly identified gene biomarker can distinguish atopic dermatitis and psoriasis with excellent accuracy

Mount Sinai researchers have pinpointed a single gene biomarker, nitride oxide synthase 2 (NOS2) that can distinguish atopic dermatitis (AD) and psoriasis with 100 percent accuracy using adhesive tape strips, a non-invasive alternative to skin biopsy. The research will be published online today in the Journal of Allergy and Clinical Immunology.

			Skin cancer therapies could be used to treat other types of tumors The creation of a silica nanocapsule could allow treatments that use light to destroy cancerous or precancerous cells in the skin to also be used to treat other types of cancer.

			siRNA-based treatment can reduce psoriasis symptoms Psoriasis, a chronic skin condition that causes itchy, red, scaly patches, afflicts more than 8 million Americans and 125 million people worldwide.

	Study reveals mechanisms of mechanical stretch induced skin expansion The capacity of the skin to expand by mechanical stretching has been used for decades in plastic and reconstructive surgery to generate an excess of skin that can be used to repair birth defects, damaged tissues, and breast reconstruction after mastectomy.

	New spatial mapping method pinpoints new potential therapeutic targets for lupus A team of researchers from Children's Hospital of Philadelphia used a new method of pinpointing potential disease-causing changes in the genome to identify two new potential therapeutic targets for lupus, while also paving the way for more accurately identifying disease-causing variations in other autoimmune disorders.

	New type of immunotherapy shows promise for advanced skin cancer A new type of immunotherapy for the skin cancer malignant melanoma shows promising results. Three severely ill patients are now long-term survivors.